DFEV
Dimensional Emerging Markets Value ETF
stock NYSE ETF

For US domestic, AVLV is great. It’s outperformed VOO by about 2% per year since inception with lower drawdowns (and similar volatility). The expense ratio is very reasonable, its factor tilts are more likely to be a durable source of outperformance than stock picking alpha, and it’s even more tax efficient than VOO (100% qualified since inception).
It does contain some megacap tech stocks, but only the ones that have reasonable valuations. You won’t get unprofitable junk or heavy IPO bags in it.
Unlike a purely passive value ETF like VTV, it has a market beta more comparable to VTI/VOO, so you’re not trading off the market exposure to simply diversify away.
Internationally, I like DFIV, AVDV, AVEM, and DFEV for similar reasons. They’ve all dramatically outperformed their MSCI benchmarks (IDEV and IEMG for developed and international) since inception, which gives me confidence that you can still outperform without overweight tech exposure and that DFA and Avantis know what they’re doing. (I am also hugely exposed to tech in my US allocation because I bought almost nothing but tech from 2022-25.)

For US domestic, AVLV is great. It’s outperformed VOO by about 2% per year since inception with lower drawdowns (and similar volatility). The expense ratio is very reasonable, its factor tilts are more likely to be a durable source of outperformance than stock picking alpha, and it’s even more tax efficient than VOO (100% qualified since inception).
It does contain some megacap tech stocks, but only the ones that have reasonable valuations. You won’t get unprofitable junk or heavy IPO bags in it.
Unlike a purely passive value ETF like VTV, it has a market beta more comparable to VTI/VOO, so you’re not trading off the market exposure to simply diversify away.
Internationally, I like DFIV, AVDV, AVEM, and DFEV for similar reasons. They’ve all dramatically outperformed their MSCI benchmarks (IDEV and IEMG for developed and international) since inception, which gives me confidence that you can still outperform without overweight tech exposure and that DFA and Avantis know what they’re doing. (I am also hugely exposed to tech in my US allocation because I bought almost nothing but tech from 2022-25.)